Health

Vnzymes Opens New European Office in Frankfurt to Accelerate Innovation in Animal Nutrition and Sustainable Agriculture

FRANKFURT, Germany, Nov. 15, 2025 (GLOBE NEWSWIRE) -- Vnzymes, the new brand and European subsidiary of VTR Biotech Group, today…

4 months ago

Sapphire RX Expands Access to Virtual Wellness Care

KNOXVILLE, Tenn., Nov. 15, 2025 (GLOBE NEWSWIRE) -- Sapphire RX advances digital health accessibility with an innovative telehealth model that…

4 months ago

Algernon Closes First Tranche of its Recently Announced Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE…

4 months ago

Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

November 14, 2025 16:05 ET  | Source: Terns Pharmaceuticals, Inc. FOSTER CITY, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Terns…

4 months ago

TOMI Environmental Solutions, Inc. Reports Q3 2025 Financial Results and Outlines Growth Initiatives

FREDERICK, Md., Nov. 14, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and…

4 months ago

Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results

–   Company reports $14.3 million in revenue in Q3’25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of…

4 months ago

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) is issuing the following…

4 months ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

INSIDE INFORMATIONREGULATED INFORMATION Correction and ReplacementNyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of…

4 months ago

LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in the United Kingdom

November 13, 2025 18:30 ET  | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Eisai…

4 months ago

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

November 12, 2025 22:55 ET  | Source: Annexon Biosciences BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”)…

4 months ago